Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A study of HER2 gene amplification and protein expression in gastric cancer

9 Aug 2010

Abstract excerpt

BACKGROUND: Gastric cancer is a leading cause of cancer-related mortality, and current treatment outcomes for advanced disease remain poor. HER2 has been identified as a potential candidate for targeted therapy in gastric cancers displaying HER2 gene amplification and protein overexpression. AIMS: To study the prevalence rate of HER2 gene amplification/overexpression in a local population, and determine the...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Gastric Cancer Management and Outcomes
Share to Gene expression and cancer classification
Share to HER2/EGFR in Cancer Research

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 20696687
DOI: 10.1136/jcp.2010.076570

Provenance

PubMed metadata and Literature Corpus relationships.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A study of HER2 gene amplification and protein expression in gastric cancerPMID 20696687Read ↗

Assessment of ERBB2 and EGFR gene amplification and protein expression in gastric carcinoma by immunohistochemistry and fluorescence in situ hybridizationSemantic proximity Read ↗

HER2 amplification in gastric cancer is a rare event restricted to the intestinal phenotype.Semantic proximity Read ↗

Human Epidermal Growth Factor Receptor-2(HER-2) expression in Sri Lankan gastric adenocarcinoma patients: An analysis of the concordance of HER2 expression and survival based on silver in-situ hybridization (SISH)Semantic proximity Read ↗

Hybridization for human epidermal growth factor receptor 2 testing in gastric carcinoma: a comparison of fluorescence in-situ hybridization with a novel fully automated dual-colour silver in-situ hybridization methodSemantic proximity Read ↗

Dual-colour HER2/Chromosome 17 chromogenic in situ hybridisation assay enables accurate assessment of HER2 genomic status in gastric cancer and has potential utility in HER2 testing of biopsy samplesSemantic proximity Read ↗

FGFR2 overexpression and compromised survival in diffuse-type gastric cancer in a large central European cohortSemantic proximity Read ↗

The validation of a novel method combining both HER2 immunohistochemistry and HER2 dual-colour silver in situ hybridization on one slide for gastric carcinoma testingSemantic proximity Read ↗

FGFR2 in gastric cancer: protein overexpression predicts gene amplification and high H-index predicts poor survival.Semantic proximity Read ↗

HER2 gene (ERBB2) amplification is a rare event in non-liver-fluke associated cholangiocarcinogenesisSemantic proximity Read ↗

A proposal for diagnostically meaningful criteria to classify increased epidermal growth factor receptor and c-erbB-2 gene copy numbers in gastric carcinoma, based on correlation of fluorescence in situ hybridization and immunohistochemical measurementsSemantic proximity Read ↗

Evaluation of gene amplification and protein expression of HER-2/neu in esophageal squamous cell carcinoma using Fluorescence in situ Hybridization (FISH) and immunohistochemistrySemantic proximity Read ↗

MET in gastric carcinomas: comparison between protein expression and gene copy number and impact on clinical outcomeSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.